Vanguard Group’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,206,509
| Closed | -$12.1M | – | 4580 |
|
|
2022
Q3 | $12.1M | Sell |
10,206,509
-1,016,728
| -9% | -$1.21M | ﹤0.01% | 2859 |
|
|
2022
Q2 | $20.2M | Sell |
11,223,237
-1,125,661
| -9% | -$2.03M | ﹤0.01% | 2636 |
|
|
2022
Q1 | $24.9M | Buy |
12,348,898
+2,233,797
| +22% | +$4.51M | ﹤0.01% | 2652 |
|
|
2021
Q4 | $27.4M | Sell |
10,115,101
-2,179,790
| -18% | -$5.91M | ﹤0.01% | 2670 |
|
|
2021
Q3 | $54.8M | Buy |
12,294,891
+2,380,823
| +24% | +$10.6M | ﹤0.01% | 2310 |
|
|
2021
Q2 | $57.5M | Buy |
9,914,068
+2,290,875
| +30% | +$13.3M | ﹤0.01% | 2293 |
|
|
2021
Q1 | $53.5M | Buy |
7,623,193
+1,235,639
| +19% | +$8.67M | ﹤0.01% | 2276 |
|
|
2020
Q4 | $30.7M | Buy |
6,387,554
+205,075
| +3% | +$984K | ﹤0.01% | 2434 |
|
|
2020
Q3 | $36M | Sell |
6,182,479
-62,445
| -1% | -$364K | ﹤0.01% | 2176 |
|
|
2020
Q2 | $42.2M | Buy |
6,244,924
+1,787,665
| +40% | +$12.1M | ﹤0.01% | 2086 |
|
|
2020
Q1 | $28.3M | Buy |
4,457,259
+238,915
| +6% | +$1.52M | ﹤0.01% | 2124 |
|
|
2019
Q4 | $44M | Sell |
4,218,344
-295,499
| -7% | -$3.08M | ﹤0.01% | 2180 |
|
|
2019
Q3 | $17.7M | Sell |
4,513,843
-67,950
| -1% | -$267K | ﹤0.01% | 2542 |
|
|
2019
Q2 | $68.1M | Sell |
4,581,793
-47,969
| -1% | -$713K | ﹤0.01% | 1949 |
|
|
2019
Q1 | $115M | Buy |
4,629,762
+68,832
| +2% | +$1.71M | ﹤0.01% | 1680 |
|
|
2018
Q4 | $81.9M | Buy |
4,560,930
+115,866
| +3% | +$2.08M | ﹤0.01% | 1789 |
|
|
2018
Q3 | $131M | Buy |
4,445,064
+104,655
| +2% | +$3.07M | 0.01% | 1663 |
|
|
2018
Q2 | $197M | Buy |
4,340,409
+349,031
| +9% | +$15.9M | 0.01% | 1357 |
|
|
2018
Q1 | $211M | Buy |
3,991,378
+69,426
| +2% | +$3.67M | 0.01% | 1257 |
|
|
2017
Q4 | $267M | Buy |
3,921,952
+51,147
| +1% | +$3.48M | 0.01% | 1104 |
|
|
2017
Q3 | $319M | Buy |
3,870,805
+251,962
| +7% | +$20.8M | 0.01% | 966 |
|
|
2017
Q2 | $339M | Buy |
3,618,843
+333,648
| +10% | +$31.2M | 0.02% | 899 |
|
|
2017
Q1 | $209M | Buy |
3,285,195
+662,969
| +25% | +$42.2M | 0.01% | 1194 |
|
|
2016
Q4 | $116M | Buy |
2,622,226
+97,762
| +4% | +$4.34M | 0.01% | 1524 |
|
|
2016
Q3 | $91M | Buy |
2,524,464
+118,996
| +5% | +$4.29M | 0.01% | 1619 |
|
|
2016
Q2 | $33M | Buy |
2,405,468
+171,047
| +8% | +$2.35M | ﹤0.01% | 2090 |
|
|
2016
Q1 | $42.9M | Buy |
2,234,421
+1,153
| +0.1% | +$22.1K | ﹤0.01% | 1937 |
|
|
2015
Q4 | $78.2M | Buy |
2,233,268
+169,332
| +8% | +$5.93M | 0.01% | 1631 |
|
|
2015
Q3 | $190M | Buy |
2,063,936
+264,515
| +15% | +$24.3M | 0.01% | 1015 |
|
|
2015
Q2 | $158M | Buy |
1,799,421
+151,772
| +9% | +$13.3M | 0.01% | 1221 |
|
|
2015
Q1 | $122M | Buy |
1,647,649
+249,857
| +18% | +$18.5M | 0.01% | 1360 |
|
|
2014
Q4 | $78.3M | Buy |
1,397,792
+47,785
| +4% | +$2.68M | 0.01% | 1575 |
|
|
2014
Q3 | $61.2M | Buy |
1,350,007
+6,866
| +0.5% | +$311K | ﹤0.01% | 1689 |
|
|
2014
Q2 | $55.6M | Buy |
1,343,141
+33,065
| +3% | +$1.37M | ﹤0.01% | 1778 |
|
|
2014
Q1 | $90.7M | Buy |
1,310,076
+53,818
| +4% | +$3.73M | 0.01% | 1413 |
|
|
2013
Q4 | $75.7M | Buy |
1,256,258
+223,216
| +22% | +$13.5M | 0.01% | 1503 |
|
|
2013
Q3 | $62.8M | Buy |
1,033,042
+289,154
| +39% | +$17.6M | 0.01% | 1566 |
|
|
2013
Q2 | $49.8M | Buy |
+743,888
| New | +$49.8M | 0.01% | 1642 |
|